Psilocybin for PTSD: What the Clinical Trials Found
PTSD is one of the most treatment-resistant mental health conditions. Here's what the emerging research on psilocybin-assisted therapy shows — and why it may work when nothing else has.
Why PTSD Is Different
Post-traumatic stress disorder is a disorder of memory consolidation — the brain gets stuck in a loop, unable to process a traumatic event as something that happened in the past. Standard talk therapy has limited effectiveness for severe PTSD because it doesn't reach the brain's threat-detection system directly.
What Psilocybin Does Differently
Research from NYU and Johns Hopkins suggests psilocybin: reduces amygdala reactivity, enables memory reconsolidation (traumatic memories can be "re-filed" as past events), and increases psychological flexibility.
A 2023 study in Nature Mental Health found psilocybin-assisted therapy produced significant reductions in PTSD symptoms in veterans who had failed multiple prior treatments.
The Microdosing Approach
Full-dose psilocybin therapy for PTSD requires clinical supervision. However, microdosing protocols show promise for managing day-to-day PTSD symptoms: hypervigilance, emotional numbing, sleep disruption, and social withdrawal.
Explore the microdosing protocol →
This article is for informational purposes only and does not constitute medical advice.
This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before making any changes to your health regimen.